The University of Queensland’s BASE facility – within the Australian Institute for Bioengineering and Nanotechnology (AIBN) – and Brisbane-based biotechnology company Vaxxas have been announced as stage winners of a prestigious global prize to accelerate a patch-based mRNA vaccine for COVID-19.
UQ and Vaxxas win global prize to accelerate patch-based mRNA vaccine for COVID-19
- Post author:admin
- Post published:January 13, 2025
- Post category:uncategorized